Abstract: The invention concerns irbesartan form A having a modified crystalline habit such that length/width ratio ranges between 1:1 and 10:1, preferably between 1:1 and 5:1 and a method for preparing said crystalline habit. The method is characterised in that it consists in either subjecting a crystalline suspension of irbesartan form A having acicular habit to at least a temperature oscillating step, or in subjecting a crystalline suspension of irbesartan form A having acicular habit to a mechanical shearing. The invention also concerns a pharmaceutical composition containing said irbesartan crystalline habit.
| # | Name | Date |
|---|---|---|
| 1 | in-pct-2000-00727-mum-wo international publication report(13-12-2000).pdf | 2000-12-13 |
| 2 | in-pct-2000-00727-mum-form 3(13-12-2000).pdf | 2000-12-13 |
| 3 | in-pct-2000-00727-mum-form 1(13-12-2000).pdf | 2000-12-13 |
| 4 | in-pct-2000-00727-mum-drawing(13-12-2000).pdf | 2000-12-13 |
| 5 | in-pct-2000-00727-mum-description(complete)-(13-12-2000).pdf | 2000-12-13 |
| 6 | in-pct-2000-00727-mum-claims(13-12-2000).pdf | 2000-12-13 |
| 7 | in-pct-2000-00727-mum-power of authority(21-6-2001).pdf | 2018-08-08 |
| 8 | in-pct-2000-00727-mum-form 19(17-5-2004).pdf | 2018-08-08 |
| 9 | in-pct-2000-00727-mum-correspondence(ipo)-(6-8-2009).pdf | 2018-08-08 |
| 10 | in-pct-2000-00727-mum-correspondence 2(15-7-2009).pdf | 2018-08-08 |
| 11 | in-pct-2000-00727-mum-correspondence 1(17-5-2004).pdf | 2018-08-08 |